Merck Vioxx heart risks began sooner: WSJ
Heart risks associated with Merck & Co.'s painkiller Vioxx began much sooner than the company has claimed, The Wall Street Journal Online reported on Tuesday, citing a new study.
Intercell wins $363 mln Novartis deal, shares jump
Austrian biotech firm Intercell won a deal to sell shares and rights to its vaccine technology to drugmaker Novartis for 270 million euros ($363 million), pushing its stock to all-time highs on Monday.
AMA to seek probe of US retail health clinics
The American Medical Association said on Monday it will ask state and federal authorities to investigate retail health clinics such as those offered in CVS/Caremark stores, Wal-Mart Stores and Walgreen Co. for possible conflicts of interest.
Bird flu silences once bustling HK songbird market
In its heyday, Hong Kong's famous Bird Garden market bustled with shoppers bargaining in Cantonese for exotic birds for sale as pets or for Buddhist rituals.
-
Addiction experts say video games not an addiction
-
Unions move toward health-care reform deal
-
Wall Street's undertow: drugs and anxiety
-
Colgate warns of fake toothpaste in U.S.
-
This Emerging Biotech Stock Jumped 1,300% on Monday After Major FDA Breakthrough Milestone
-
'TrumpRx': President Unveils New Drug Price-Cutting Website As Pfizer Agrees To Slash Costs By 50%
More news
Top Indian Heart Doctor Leaves Longtime Home
Last week, Dr. Naresh Trehan, the top cardiologist at one of India’s largest corporate hospital groups, playing the role of a modern-day Moses, quit the research center he had led for the last 20 years, triggering an exodus of sorts, with about 50 doctors set to follow him to a rival hospital.
Advanced’s Bid for Bausch Could Trigger Bid War
Advanced Medical Optics Inc. (NYSE: EYE) said it is considering an offer for Bausch & Lomb Inc. (NYSE: BOL), setting up what could become bidding war with the private equity firm Warburg Pincus LLC.
Product Safety Rules Tightened in Japan
The Ministry of Economy, Trade and Industry in Japan is now requiring home appliance manufacturers to report serious accidents caused by their products, according to a report by Asashi Shimbun on Monday.
J&J Stops Stent Study, Discontinues Sales
Johnson & Johnson wholly owned firm Conor Medsystems LLCsaid, said on Monday that it will end clinical trials of its CoStar drug coated stent after it failed to meet its primary goal.
Amgen Shares Rise on Drug Trial Results
Shares of biotechnology firm Amgen, Inc. (Nasdaq: AMGN) shot up 4 percent Thursday, after results of a study for its Aranesp anemia drug for patients with small-cell lung cancer yielded no difference in survival rates than for patients who did not use the drug.
Top U.S. Court Backs Ban on Abortion Procedure
The Supreme Court upheld the nationwide ban on a controversial abortion procedure Wednesday, handing abortion opponents the long-awaited victory they expected from a more conservative bench.
Cell Genesys Up Sharply on Clinical Trial Results
Biotechnology firm Cell Genesys Inc. (Nasdaq: CEGE) shares rose sharply Tuesday, after the company said its prostate cancer drug therapy showed better-than-expected results in a clinical trial.
Drug Maker Cephalon Rises on Upgrade
Shares of drug maker Cephalon (NASDAQ: Cephalon) jumped in Monday trading as a Wall Street Brokerage Firm raised the rating of the stock on Monday despite a delay in approval for a new drug.
Novavax Shares Leap on Flu Test Results
Shares of biotechnology firm Novavax (Nasdaq: NVAX) leaped in morning trading following an announcement that its vaccine against avian flu seems effective in small animals.
Nuvelo Rallies on Drug's ‘Fast-Track' Status
Shares of Nuvelo, Inc. (Nasdaq: NUVO) skyrocketed on Tuesday following news that drug maker's cancer drug was granted 'fast-track' status by the U.S. Food and Drug Administration.
Regeneron Shares Rocket on Study Results
Shares of Regeneron Paharmaceuticals, Inc. (Nasdaq: REGN) soared Tusday after initial results of a study involving treatment to prevent a leading cause of age-related acquired blindness showed significant results.
Alexza Shares Skyrocket on Drug Trial Results
Drug maker Alexza Pharmaceuticals, Inc. (Nasdaq:ALXA) said that two of its drugs for treating schizophrenic patients showed positive initial results in clinical trials, sending its shares skyrocketing.
Boston Sci Shares Down, Abbot Up on Stent Report
Shares of Boston Scientific (NYSE: BSX) dropped to their lowest price since 2002 on Monday, while shares of Abbott laboratories (NYSE: ABT) rose after a medical study showed that Abbot's stent device was better at treating clogged heart arteries.
FDA OKs Consumer Laser to Treat Baldness: Firm
U.S. health officials have cleared a hair-combing consumer laser product to treat baldness in men, the manufacturer said Thursday.
U.S. Approves First Non-Prescription Diet Pill
The first U.S. non-prescription weight loss pill was approved this week by U.S. health officials.
Food Store Marketing Confronts Big Waistlines
With the New Year sure to bring many weight loss resolutions, fast-casual restaurant Boston Market is launching a web marketing promotion to present its food offerings as healthy and affordable solutions for reducing excess belly fat.
Depression is Top Researched Condition Online
More consumers are utilizing the internet for researching prescription medication information, a new study finds, with depression remaining the leading condition researched online.
Sony Introduces HD Surgery Equipment
Sony Electronics introduced high-definition technology for medical surgery on Monday, rolling out equipment allowing practitioners to see details of patients at never-before resolutions.
Wal-Mart Drug Rollout Four Months Early
Wal-Mart said Thursday it will implement its $4 generic prescription program in Florida tomorrow. The rollout comes four months earlier than originally planned.
Have bonus, will botox: financiers splurge
Financiers have found a perfect way to splurge their annual bonuses cosmetic surgery to keep them looking youthful in a fiercely competitive job market.
Battle Againt Stress Means Big Business
Sarah Kugelman once suffered so much work-related stress that her doctor told her to change her lifestyle or risk dying before the age of 40.
Mixed verdict for Glaxo in EU drug export case
GlaxoSmithKline won a partial victory on Wednesday in its bid to stop Spanish drug wholesalers from re-exporting its medicines at high premiums.
Pages
- Prev
- 242
- 243
- 244
- 245
- 246
- 247
- Next
- Promoted in Grammy award
- 1
- 2
- 3
- 4
- 5
Editor's pick
-
New Data Showed Consumer Sentiment and Retail Sales Declined In July. Stocks Declined.
-
Sandisk Has Had a Scorching Rally This Year. JPMorgan Thinks It Can Go Much Higher.
-
Jeff Bezos Is Now Dabbling In Sports As Part Of a Group With Minority Ownership In a Premier League Giant
-
There Is No End To The U.S.-Iran War In Sight. Just Two Ships Made It Through The Hormuz Strait On Friday.
-
Microsoft Copilot Predicts $0.65 Cardano by 2027. Whales Are Already Buying.
-
China's AI Models Are Catching Up. Z.ai's GLM-5.3 Takes Aim at OpenAI & Anthropic
